Skip to content

Use CD4 cell count, not CD4 cell percentage to guide treatment decisions in all patients with HIV, even those with cirrhosis

IAS: Maraviroc produces best results when combined with another active drug

IAS: Boosted atazanavir shows edge over unboosted in treatment-naive after 96 weeks

Were host factors or superinfection the key to case of rapid HIV progression?

Over 50s do just as well on HIV treatment, but more likely to be diagnosed late and to change treatment sooner

IAS: HPV diversity suggests value of HIV-positive gay men receiving Gardasil

MMR revaccination safe and effective in children taking successful anti-HIV treatment

IAS: Incidence of some cancers increasing significantly in HIV-positive individuals

South Africa reports slight decline in HIV prevalence among pregnant women